Zobrazeno 1 - 5
of 5
pro vyhledávání: '"C J, Doggen"'
Publikováno v:
Thrombosis and haemostasis. 84(5)
The HR2 haplotype of the factor V gene, which contains the histidine to arginine substitution at position 1299, has been reported to be associated with reduced factor V levels. Because high factor V levels have been found to be associated with an inc
Publikováno v:
British journal of haematology. 110(4)
In the Study of Myocardial Infarctions Leiden, we investigated the prevalence of three polymorphisms in the alpha- and beta-fibrinogen genes among 560 patients with a myocardial infarction and 646 control subjects. Secondly, we studied the relationsh
Publikováno v:
Thrombosis and haemostasis. 82(1)
Several studies have found an association between high plasminogen activator inhibitor-1 (PAI-1) levels and myocardial infarction. Whether this is causal or a consequence of atherosclerosis or tissue damage, remains unclear. Homozygous carriers of th
Autor:
C J, Doggen, G, Kunz, F R, Rosendaal, D A, Lane, H L, Vos, P J, Stubbs, V, Manger Cats, H, Ireland
Publikováno v:
Thrombosis and haemostasis. 80(5)
Thrombomodulin is an endothelial cell surface receptor that transforms the procoagulant thrombin into an anticoagulant. A mutation in the thrombomodulin gene is a potential risk factor for venous and arterial thrombosis. We screened a region within t
Autor:
F R, Rosendaal, C J, Doggen, A, Zivelin, V R, Arruda, M, Aiach, D S, Siscovick, A, Hillarp, H H, Watzke, F, Bernardi, A M, Cumming, F E, Preston, P H, Reitsma
Publikováno v:
Thrombosis and haemostasis. 79(4)
A variant in prothrombin (clotting factor II), a G to A transition at nucleotide position 20210, has recently been shown to be associated with the prothrombin plasma levels and the risk of both venous and arterial thrombosis. The purpose of this stud